Argyle Capital Management Inc. has filed its 13F form on July 29, 2024 for Q2 2024 where it was disclosed a total value porftolio of $240 Million distributed in 122 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $13M, Eli Lilly & CO with a value of $11.4M, Mckesson Corp with a value of $7.45M, Merck & Co., Inc. with a value of $7.02M, and Amgen Inc with a value of $6.18M.
Examining the 13F form we can see an decrease of $14.6M in the current position value, from $255M to 240M.
Below you can find more details about Argyle Capital Management Inc. portfolio as well as his latest detailed transactions.
Portfolio value
$240 Million
Healthcare: $52.7 Million
Technology: $38.9 Million
Industrials: $33.9 Million
Financial Services: $30.2 Million
Energy: $20.8 Million
Consumer Cyclical: $18.1 Million
Consumer Defensive: $13.8 Million
Utilities: $11.7 Million
Other: $20.4 Million
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
